Figure 3From: High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapyThe hs-TnT level at 6 months predicts a reduction of LVEF at 15 months.(A) The correlation between the changes of high-sensitivity troponin T (∆hs-TnT) at 6 months and the changes of left ventricular ejection fraction (∆LVEF) at 15 months. (B) The dot diagram depicting the distribution of hs-TnT at 6 months in each group. (C) The ROC curve analysis of hs-TnT at 6 months in both groups. The transverse dot line in (B) and the arrow in (C) indicate the cutoff point of hs-TnT that provides the maximum value by adding sensitivity to specificity.Back to article page